Recently, DuPont launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The company’s bioprocessing solutions are designed to enable sophisticated purifications and separations for therapeutics and diagnostics, with established brands such as DuPont AMBERCHROM and DuPont AMBERLITE
INDUSTRY NEWS
- Read More
As more companies explore oligonucleotides as part of their biopharma drug pipeline, the importance of developing an effective HPLC method is increasing. While
starting points for mobile phases, ion pairing agent, and example HPLC methods can be found in the literature, often these methods do not transfer across oligos.Posted: July 07, 2022 - Read More
Dorie Yontz of DuPont discusses its bioprocessing offering, the role of polymeric resins, and critical elements as they relate to manufacturing.
Image: DuPontPosted: April 06, 2022 - Read More
Emerging drug classes are giving rise to challenges in downstream processing, pushing the need for strategizing efficiencies.
The global downstream processing (DSP) market is predicted to experience compound annual growth rate of 16.09% between 2021 and 2027 (1). This market growth is reportedly being driven by the expanding biopharmaceutical industry and spending in medical research, the rising adoption of single-use technology in bioprocessing, and the swell of contract manufacturing organizations in the market for DSP (1).
To learn more about purification and separation of biopharmaceuticals, the fundamental challenges facing developers, ways in which companies can overcome bottlenecks associated with DSP, sustainability considerations, and other trends impacting this sector, BioPharm International spoke with Dorie Yontz, global market manager, Bioprocessing, DuPont Water Solutions, and Hans J. Johansson,
Posted: April 06, 2022 -
Read MoreWILMINGTON, Del., February 8, 2022, – DuPont (NYSE:DD) has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week.
DuPont’s bioprocessing solutions enable sophisticated purifications and separations for therapeutics and diagnostics, with brands such as DuPont™ AmberChrom™ and DuPont™ AmberLite™ being well established in the biopharma industry. Its products are used to purify process streams during drug and diagnostic kit manufacturing. Although these products are not part of the finished formulation, purification resins are critical to final product quality and are therefore selected early in drug development.
The e-store is created in collaboration with DWS Advantage, a Xenon arc entity, and provides customers with direct access to DuPont products while still giving them personalized
Posted: March 18, 2022 -
Read MoreDuPont Water Solutions and Xenon arc Launch directibility™
BELLEVUE, Wash.--(BUSINESS WIRE)--DuPont Water Solutions,
Posted: April 26, 2021 -
Read MoreWe are pleased to present the new look online home of DWS Advantage!
Posted: March 08, 2021